Skip to main content
SpringerLink
Log in

Other Challenging Therapies

  • Chapter
  • First Online:
Kawasaki Disease

  • 1280 Accesses

Abstract

Previous chapters described initial and rescue treatment for patients with Kawasaki disease. Other immunosuppressive agents, such as biological agents, methotrexate, cyclophosphamide, and plasma exchange, may also be effective for patients with Kawasaki disease. However, most of these agents have not been carefully evaluated for their efficacy in suppressing inflammation due to Kawasaki disease and preventing formation of coronary artery lesions, and most of the present evidence is from case reports or case series. Further research is needed before recommendations can be developed for these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Choueiter NF, Olson AK, Shen DD, Portman MA. Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease. J Pediatr. 2010;157(6):960–6. http://dx.doi.org/10.1016/j.jpeds.2010.06.014 PMID:20667551.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chen S, Lee Y, Crother TR, Fishbein M, Zhang W, Yilmaz A, et al. Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease. Arterioscler Thromb Vasc Biol. 2012;32(8):e60–71. http://dx.doi.org/10.1161/ATVBAHA.112.249417 PMID:22628430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cohen S, Tacke CE, Straver B, Meijer N, Kuipers IM, Kuijpers TW. A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation. Ann Rheum Dis. 2012;71(12):2059–61. http://dx.doi.org/10.1136/annrheumdis-2012-201658 PMID:22689319.

    Article  PubMed  Google Scholar 

  4. Sauvaget E, Bonello B, David M, Chabrol B, Dubus JC, Bosdure E. Resistant Kawasaki disease treated with anti-CD20. J Pediatr. 2012;160(5):875–6. http://dx.doi.org/10.1016/j.jpeds.2012.01.018 PMID:22341587.

    Article  PubMed  Google Scholar 

  5. Lee MS, An SY, Jang GC, Kim DS. A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate. Yonsei Med J. 2002;43(4):527–32. http://dx.doi.org/10.3349/ymj.2002.43.4.527 PMID:12205742.

    Article  PubMed  Google Scholar 

  6. Ahn SY, Kim DS. Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate. Scand J Rheumatol. 2005;34(2):136–9. PMID:16095010.

    CAS  PubMed  Google Scholar 

  7. Lee TJ, Kim KH, Chun JK, Kim DS. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease. Yonsei Med J. 2008;49(5):714–18. http://dx.doi.org/10.3349/ymj.2008.49.5.714 PMID:18972590.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics. 2000;105(6):E78. http://dx.doi.org/10.1542/peds.105.6.e78 PMID:10835091.

    Article  CAS  PubMed  Google Scholar 

  9. Takagi N, Kihara M, Yamaguchi S, Tamura K, Yabana M, Tokita Y, et al. Plasma exchange in Kawasaki disease. Lancet. 1995;346(8985):1307. http://dx.doi.org/10.1016/S0140-6736(95)91916-3 PMID:7475760.

    Article  CAS  PubMed  Google Scholar 

  10. Imagawa T, Mori M, Miyamae T, Ito S, Nakamura T, Yasui K, et al. Plasma exchange for refractory Kawasaki disease. Eur J Pediatr. 2004;163(4–5):263–4. http://dx.doi.org/10.1007/s00431-003-1267-y PMID:14986117.

    Article  PubMed  Google Scholar 

  11. Hokosaki T, Mori M, Nishizawa T, Nakamura T, Imagawa T, Iwamoto M, et al. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease. Pediatr Int. 2012;54(1):99–103. http://dx.doi.org/10.1111/j.1442-200X.2011.03487.x PMID:22004042.

    Article  CAS  PubMed  Google Scholar 

  12. Fujimaru T, Ito S, Masuda H, Oana S, Kamei K, Ishiguro A, et al. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Cytokine. 2014;70(2):156–60. http://dx.doi.org/10.1016/j.cyto.2014.07.003 PMID:25082649.

    Article  CAS  PubMed  Google Scholar 

  13. Research Committee of the Japanese Society of Pediatric CardiologyCardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease. Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatr Int. 2014;56(2):135–58. http://dx.doi.org/10.1111/ped.12317 PMID:24730626.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Research Planning, Department of Development Strategy, Center for Clinical Research and Development, National Center for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, 157-8535, Japan

    Tohru Kobayashi M.D., Ph.D.

Authors
  1. Tohru Kobayashi M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tohru Kobayashi M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Advanced and Integrated Cardiovascular Research Course in the Young and Adolescence, Toho University, Tokyo, Japan

    Ben Tsutomu Saji

  2. Boston Children’s Hospital, Harvard Medical School, Department of Cardiology, Boston, Massachusetts, USA

    Jane W. Newburger

  3. Department of Pediatrics, Rady Children’s Hospital, University of California San Diego School of Medicine, La Jolla, USA

    Jane C. Burns

  4. Heart Center , Seattle Childrens Hospital, Seattle, USA

    Masato Takahashi

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan

About this chapter

Cite this chapter

Kobayashi, T. (2017). Other Challenging Therapies. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56039-5_21

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56037-1

  • Online ISBN: 978-4-431-56039-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation